Skip to main content
Premium Trial:

Request an Annual Quote

DASA Offering Natera's Panorama NIPD in Brazil

NEW YORK (GenomeWeb News) – DASA Group and Natera have reached a deal to offer Natera's non-invasive prenatal diagnostic test in Brazil, the companies announced on Thursday.

Financial and other terms were not disclosed.

Called Panorama, Natera's test detects trisomy 21, 18, and 13 and monosomy X with a simple blood draw from the mother. Panorama was launched in December.

In June, San Carlos, Calif.-based Natera announced a deal with Unilabs to offer the test in Switzerland and Scandinavia. Natera also has distribution deals with Arup Laboratories, Quest Diagnostics, and Bio-Reference Laboratories.

DASA, based in Sao Paulo, offers diagnostic services in Brazil. Panorama will be offered through the Delboni brands Sergio Franco and Alta, which are part of DASA.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.